Difference between revisions of "Team:Vilnius-Lithuania/Design"

Line 1,342: Line 1,342:
 
             <div class="img-label">Figure 3. Different plasmid groups can be co-maintained in a cell with a specific, pre-selected copy number. Copy number control principle is the same for every plasmid group, but both RNA I and RNA II molecules are only specific to their own.
 
             <div class="img-label">Figure 3. Different plasmid groups can be co-maintained in a cell with a specific, pre-selected copy number. Copy number control principle is the same for every plasmid group, but both RNA I and RNA II molecules are only specific to their own.
 
       <p>These different plasmid groups can then be co-maintained in cell with a specific, pre-selected copy number. Copy number control principle is the same for every group, but each group is only specific to its own group.</p>
 
       <p>These different plasmid groups can then be co-maintained in cell with a specific, pre-selected copy number. Copy number control principle is the same for every group, but each group is only specific to its own group.</p>
</div>
 
        </div>
 
  
<h1>Results
+
 
</h1>
+
<h1>Results</h1>
<h2>Choosing the suitable pairs
+
<h2>Choosing the suitable pairs</h2>
</h2>
+
 
   <p>The first step in experimentally choosing the suitable RNA I-RNA II pairs was done by employing a system that was able to measure the trans-acting effect of each RNA I type of group A has on the RNA II group A (BBa_K2259000) (RNA I types: WT (BBa_K2259005), NC (BBa_K2259024) and GC (BBa_K2259006)). By co-transforming base vector 2.0 (BBa_K2259081) having an A group RNA II together with pSB4A5 plasmid, which is constantly expressing one the mentioned RNA I. The plasmid copy number per cell was determined for each co-transformation using the absolute quantification qPCR.
 
   <p>The first step in experimentally choosing the suitable RNA I-RNA II pairs was done by employing a system that was able to measure the trans-acting effect of each RNA I type of group A has on the RNA II group A (BBa_K2259000) (RNA I types: WT (BBa_K2259005), NC (BBa_K2259024) and GC (BBa_K2259006)). By co-transforming base vector 2.0 (BBa_K2259081) having an A group RNA II together with pSB4A5 plasmid, which is constantly expressing one the mentioned RNA I. The plasmid copy number per cell was determined for each co-transformation using the absolute quantification qPCR.
 
</p><p>
 
</p><p>
Line 1,487: Line 1,484:
 
         <p><div class="img-cont">
 
         <p><div class="img-cont">
 
             <img src="https://static.igem.org/mediawiki/2017/d/d3/3vln.png" alt="img">
 
             <img src="https://static.igem.org/mediawiki/2017/d/d3/3vln.png" alt="img">
             <div class="img-label">KA PARASYTI
+
             <div class="img-label">Figure 3. The schematic representation of SynORI 4 plasmid selection gene circuit.
 
             </div>
 
             </div>
 
         </div></p><p>
 
         </div></p><p>
Line 1,513: Line 1,510:
 
         <p>In addition to split antibiotic system, we were able to co-transform 4 plasmids using only kanamycin as the selection marker by implementing a riboregulatory system upstream of the previously described divided neo gene. We employed toehold switches, an orthogonal translational regulation devices, to lock the protein synthesis of the corresponding split subunits (parts: BBa_K2259034 and BBa_K2259035). Furthermore, constantly expressed RNA trigger sequences (parts: BBa_K2259038 and BBa_K2259040) were added into additional two plasmids to complete the 4 plasmid genetic circuit. Our team has developed and optimized an electroporation protocol to carry out our transformation needs.
 
         <p>In addition to split antibiotic system, we were able to co-transform 4 plasmids using only kanamycin as the selection marker by implementing a riboregulatory system upstream of the previously described divided neo gene. We employed toehold switches, an orthogonal translational regulation devices, to lock the protein synthesis of the corresponding split subunits (parts: BBa_K2259034 and BBa_K2259035). Furthermore, constantly expressed RNA trigger sequences (parts: BBa_K2259038 and BBa_K2259040) were added into additional two plasmids to complete the 4 plasmid genetic circuit. Our team has developed and optimized an electroporation protocol to carry out our transformation needs.
 
</p>
 
</p>
        <div class="img-cont">
+
     
            <img src="http://placehold.it/800x450"" alt="img">
+
            <div class="img-label">Figure 6. Results of four plasmid co-transformation containing constantly expressed toehold locked α and β split kanamycin antibiotic resistance gene and trigger RNA sequences.
+
 
+
            </div>
+
        </div> 
+
 
<p>It is important to note that, in contrast to our SynORI framework, all four plasmids were the same (pSB1C3) - it had identical replicons. As a result, the selection system became unstable after long period of growth due to replicon cross-interaction. Nevertheless, as you can see from Table 1., carrying out similar experiments with 4 different antibiotics produced zero bacterial growth!</p>
 
<p>It is important to note that, in contrast to our SynORI framework, all four plasmids were the same (pSB1C3) - it had identical replicons. As a result, the selection system became unstable after long period of growth due to replicon cross-interaction. Nevertheless, as you can see from Table 1., carrying out similar experiments with 4 different antibiotics produced zero bacterial growth!</p>
 
<p><center>Table 1. Experimental data of 4 plasmid electroporation results.</center></p>
 
<p><center>Table 1. Experimental data of 4 plasmid electroporation results.</center></p>
Line 1,601: Line 1,593:
 
         <div class="img-cont">
 
         <div class="img-cont">
 
             <img src="https://static.igem.org/mediawiki/2017/3/3f/7vln.png" alt="img">
 
             <img src="https://static.igem.org/mediawiki/2017/3/3f/7vln.png" alt="img">
             <div class="img-label">Figure 7. Result of SynORI 5 plasmid selection system electroporation. The 4th field includes all the framework parts. 1 - No trigger 1 (control). 2 - No trigger 2 (control). 3 - No lambda activator plasmid (control). 4 - Full System: lambda activator plasmid; toehold 1 α-neo; toehold 2 β-neo; trigger 1; trigger 2.
+
             <div class="img-label">Figure 6. Result of SynORI 5 plasmid selection system electroporation. The 4th field includes all the framework parts. 1 - No trigger 1 (control). 2 - No trigger 2 (control). 3 - No lambda activator plasmid (control). 4 - Full System: lambda activator plasmid; toehold 1 α-neo; toehold 2 β-neo; trigger 1; trigger 2.
 
             </div>
 
             </div>
 
         </div>   
 
         </div>   

Revision as of 03:42, 2 November 2017

use keyboard, swipe or scroll

Determining the plasmid copy number

Design and Results

Preparing for the framework: standard curve generation and plasmid copy number evaluation.

read more